Network preservation reveals shared and unique biological processes associated with chronic alcohol abuse in NAc and PFC.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 24 09 2020
accepted: 27 11 2020
entrez: 17 12 2020
pubmed: 18 12 2020
medline: 4 2 2021
Statut: epublish

Résumé

Chronic alcohol abuse has been linked to the disruption of executive function and allostatic conditioning of reward response dysregulation in the mesocorticolimbic pathway (MCL). Here, we analyzed genome-wide mRNA and miRNA expression from matched cases with alcohol dependence (AD) and controls (n = 35) via gene network analysis to identify unique and shared biological processes dysregulated in the prefrontal cortex (PFC) and nucleus accumbens (NAc). We further investigated potential mRNA/miRNA interactions at the network and individual gene expression levels to identify the neurobiological mechanisms underlying AD in the brain. By using genotyped and imputed SNP data, we identified expression quantitative trait loci (eQTL) uncovering potential genetic regulatory elements for gene networks associated with AD. At a Bonferroni corrected p≤0.05, we identified significant mRNA (NAc = 6; PFC = 3) and miRNA (NAc = 3; PFC = 2) AD modules. The gene-set enrichment analyses revealed modules preserved between PFC and NAc to be enriched for immune response processes, whereas genes involved in cellular morphogenesis/localization and cilia-based cell projection were enriched in NAc modules only. At a Bonferroni corrected p≤0.05, we identified significant mRNA/miRNA network module correlations (NAc = 6; PFC = 4), which at an individual transcript level implicated miR-449a/b as potential regulators for cellular morphogenesis/localization in NAc. Finally, we identified eQTLs (NAc: mRNA = 37, miRNA = 9; PFC: mRNA = 17, miRNA = 16) which potentially mediate alcohol's effect in a brain region-specific manner. Our study highlights the neurotoxic effects of chronic alcohol abuse as well as brain region specific molecular changes that may impact the development of alcohol addiction.

Identifiants

pubmed: 33332381
doi: 10.1371/journal.pone.0243857
pii: PONE-D-20-30169
pmc: PMC7745987
doi:

Substances chimiques

MicroRNAs 0
Metallothionein 9038-94-2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0243857

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH118239
Pays : United States
Organisme : NIAAA NIH HHS
ID : R21 AA022749
Pays : United States
Organisme : NIAAA NIH HHS
ID : F31 AA028180
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA022537
Pays : United States
Organisme : NIAAA NIH HHS
ID : R28 AA012725
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Neuroscience. 2009 Jan 12;158(1):126-36
pubmed: 18353558
Brain Res. 2006 Dec 6;1123(1):1-11
pubmed: 17045977
Neuropsychopharmacology. 2010 Jan;35(1):217-38
pubmed: 19710631
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Psychol Med. 2015 Apr;45(5):1061-72
pubmed: 25171596
Biol Psychiatry. 2018 Aug 1;84(3):202-212
pubmed: 29580570
Neuropsychopharmacology. 2006 Jul;31(7):1574-82
pubmed: 16292326
Alcohol Clin Exp Res. 2020 Dec;44(12):2468-2480
pubmed: 33067813
BMC Bioinformatics. 2016 Nov 25;17(1):483
pubmed: 27884101
Oncogene. 2009 Apr 9;28(14):1714-24
pubmed: 19252524
Alcohol Res Health. 2008;31(3):185-95
pubmed: 19881886
Nat Commun. 2019 Apr 2;10(1):1499
pubmed: 30940813
Nat Hum Behav. 2019 Sep;3(9):950-961
pubmed: 31358974
Int Rev Neurobiol. 2010;91:289-320
pubmed: 20813246
Br J Pharmacol. 2017 Aug;174(16):2716-2738
pubmed: 28585320
Cell Signal. 2004 Jul;16(7):763-7
pubmed: 15115655
Clin Chem. 2010 Jun;56(6):998-1006
pubmed: 20378769
Nat Rev Neurosci. 2016 Sep;17(9):576-91
pubmed: 27444358
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Sep;27(6):951-61
pubmed: 14499312
Neuropharmacology. 2017 Aug 1;122:161-174
pubmed: 28254370
Nat Neurosci. 2005 Nov;8(11):1442-4
pubmed: 16251985
Eur J Biochem. 1987 Sep 1;167(2):195-201
pubmed: 3622514
Neuron. 2014 May 7;82(3):511-21
pubmed: 24811376
Trends Immunol. 2007 Mar;28(3):138-45
pubmed: 17276138
PLoS Comput Biol. 2011 Jan 20;7(1):e1001057
pubmed: 21283776
Mol Psychiatry. 2015 Nov;20(11):1438-47
pubmed: 25450227
Lancet. 2009 Jun 27;373(9682):2223-33
pubmed: 19560604
Nucleic Acids Res. 2003 Feb 15;31(4):e15
pubmed: 12582260
Basic Clin Pharmacol Toxicol. 2020 Apr;126(4):389-398
pubmed: 31628824
PLoS One. 2013 Apr 17;8(4):e61505
pubmed: 23613865
Brain Res. 2015 Dec 2;1628(Pt A):29-39
pubmed: 25838241
Oncol Rep. 2013 Jul;30(1):399-406
pubmed: 23674142
Pharmacogenomics J. 2003;3(1):27-40
pubmed: 12629581
Int J Psychophysiol. 2017 May;115:13-23
pubmed: 27993610
Mol Psychiatry. 2020 Jul 1;:
pubmed: 32612250
Annu Rev Pharmacol Toxicol. 2009;49:57-71
pubmed: 18834313
Nat Neurosci. 2002 Dec;5(12):1279-87
pubmed: 12411960
Drug Alcohol Depend. 2019 Apr 1;197:271-279
pubmed: 30875648
Prog Brain Res. 2012;195:191-218
pubmed: 22230628
Genes Brain Behav. 2016 Jan;15(1):169-86
pubmed: 26643147
PLoS One. 2015 Mar 24;10(3):e0121522
pubmed: 25803291
Alcohol Res Health. 2002;26(3):214-8
pubmed: 12875050
PLoS One. 2015 Sep 18;10(9):e0137671
pubmed: 26381263
Sci Rep. 2018 Oct 29;8(1):15983
pubmed: 30374078
Alcohol Clin Exp Res. 2016 Nov;40(11):2260-2270
pubmed: 27650785
Neuropsychiatr Dis Treat. 2013;9:1499-512
pubmed: 24109187
Alcohol Alcohol. 2009 Mar-Apr;44(2):136-40
pubmed: 19147798
J Neurosci Methods. 2007 Sep 30;165(2):198-209
pubmed: 17628689
Front Mol Neurosci. 2018 Apr 05;11:102
pubmed: 29674951
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
Prog Neurobiol. 2018 Dec;171:32-49
pubmed: 30316901
Am J Hum Genet. 2011 Mar 11;88(3):283-93
pubmed: 21397060
J Neurochem. 2005 Apr;93(2):359-70
pubmed: 15816859
J Neuroimmune Pharmacol. 2009 Dec;4(4):399-418
pubmed: 19655259
Cell. 2008 Jan 11;132(1):9-14
pubmed: 18191211
Alcohol. 2013 Aug;47(5):367-80
pubmed: 23714385
Cell. 2008 Feb 22;132(4):645-60
pubmed: 18295581
Alcohol Clin Exp Res. 2014 Jan;38(1):1-8
pubmed: 24033426
Neurochem Int. 1995 Jul;27(1):23-33
pubmed: 7655345
Arch Gen Psychiatry. 2003 Sep;60(9):929-37
pubmed: 12963675
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
Nat Genet. 2005 Jul;37(7):710-7
pubmed: 15965475
Brain Struct Funct. 2018 Apr;223(3):1275-1296
pubmed: 29110094
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):E2851-7
pubmed: 24982181
Eur J Nutr. 2018 Oct;57(7):2313-2322
pubmed: 29177978

Auteurs

Eric Vornholt (E)

Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Integrative Life Sciences Doctoral Program, Virginia Commonwealth University, Richmond, Virginia, United States of America.

John Drake (J)

Department of Psychiatry and Behavioral Sciences, Texas A&M University, Bryan, Texas, United States of America.

Mohammed Mamdani (M)

Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America.

Gowon McMichael (G)

Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America.

Zachary N Taylor (ZN)

Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America.

Silviu-Alin Bacanu (SA)

Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Department Psychiatry, Virginia Commonwealth University, Richmond, Virginia, United States of America.

Michael F Miles (MF)

Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America.
VCU-Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, United States of America.

Vladimir I Vladimirov (VI)

Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Department of Psychiatry and Behavioral Sciences, Texas A&M University, Bryan, Texas, United States of America.
Center for Biomarker Research and Precision Medicine, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Department of Physiology & Biophysics, Virginia Commonwealth University, Richmond, Virginia, United States of America.
School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Lieber Institute for Brain Development, Johns Hopkins University, Baltimore, Maryland, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH